{
    "2021-04-12": [
        [
            {
                "time": "2021-04-15",
                "original_text": "COVID-19 cases keep surging in some U.S. states, and Michigan governor continues plea for more vaccines as shots in arms hits daily record",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "cases",
                        "surging",
                        "vaccines",
                        "record"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Lilly says U.S. government modified purchases of its COVID-19 antibody treatments",
                "features": {
                    "keywords": [
                        "Lilly",
                        "U.S.",
                        "government",
                        "modified",
                        "purchases",
                        "antibody",
                        "treatments"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "The Zacks Analyst Blog Highlights: Oracle, Eli Lilly and BP",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Oracle",
                        "Eli Lilly",
                        "BP"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "UPDATE 1-Eli Lilly to focus on selling COVID-19 antibody drug combination",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "focus",
                        "selling",
                        "COVID-19",
                        "antibody",
                        "drug",
                        "combination"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Eli Lilly ends supply agreement with U.S. govt for COVID-19 antibody drug",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "ends",
                        "supply",
                        "agreement",
                        "U.S.",
                        "govt",
                        "COVID-19",
                        "antibody",
                        "drug"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Lilly modified COVID-19 purchase agreement for bamlanivimab alone with the U.S. government and is focusing on supply of bamlanivimab and etesevimab together",
                "features": {
                    "keywords": [
                        "Lilly",
                        "modified",
                        "COVID-19",
                        "purchase",
                        "agreement",
                        "bamlanivimab",
                        "U.S.",
                        "government",
                        "focusing",
                        "supply"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}